Investing

Wave Life Sciences : WVE

WVE

Stock Data

$7.32

$0.26 (3.68%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Wave Life Sciences Ltd is a pioneering force in genetic medicine, focusing on creating innovative treatments for serious diseases. With its proprietary PRISM platform, the company specializes in designing and producing stereopure oligonucleotides, aiming to correct genetic mutations and modulate protein activity. Its diverse pipeline includes potential therapies for amyotrophic lateral sclerosis, Huntington’s disease, Duchenne muscular dystrophy, and Alpha-1 antitrypsin deficiency, among others. Collaborating with industry giants like Pfizer and Takeda, Wave Life Sciences is at the forefront of addressing unmet medical needs through groundbreaking research.

All Wave Life Sciences Articles

2 Articles

Joel South | Mar 27, 2026 at 10:00 AM EDT

Wave Life Sciences Slips as Obesity Data Fails to Convince

Wave Life Sciences (NASDAQ:WVE) shares are trading near historic lows after two Wall Street firms cut their price targets following…

Trey Thoelcke | Dec 17, 2025 at 8:45 AM EST

Share Offerings Prompt Huge Insider Buying in These 3 Biotechs

Secondary offerings from biotechs Immunovant, Kymera Therapeutics, and Wave Life Sciences prompted some huge insider buying recently.